Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-29

FDA Approved: NOREPINEPHRINE BITARTRATE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved norepinephrine bitartrate injection from Sun Pharmaceutical Industries as an original-application generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norepinephrine bitartrate injection (Norepinephrine bitartrate)

Snippet

ORIG AP for NOREPINEPHRINE BITARTRATE (NOREPINEPHRINE BITARTRATE)